| Page No 1 |
| Phrase | Consultant | Town | Special Interests |
| Airway research - lead for research and development | *Consultant(s)* | *Towns* | Airway research - lead for research and development, renal anaesthesia, NHS trust lead for innovations in anaesthesia, research and development lead for anaesthesia |
| antibacterial drug development | *Consultant(s)* | *Towns* | Antimicrobial resistance, infection outcomes research, antimicrobial pharmacokinetics and dynamics, antibacterial drug development, medical microbiology |
| child development | *Consultant(s)* | *Towns* | Neurodisability, adoption and fostering, child development, complex health needs, epilepsy |
| children with disorders of sex development - DSD | *Consultant(s)* | *Towns* | Children of short stature, children with disorders of sex development - DSD, adolescents with gender dysphoria |
| Development of cancer vaccines | *Consultant(s)* | *Towns* | Development of cancer vaccines, adoptive T-cell therapy of cancer, gene therapy of cancer |
| development of new treatments for psychosis | *Consultant(s)* | *Towns* | Mechanisms underlying psychotic symptoms and psychosis, development of new treatments for psychosis |
| device development and evaluation (CE-marking) | *Consultant(s)* | *Towns* | Diagnostic and interventional neuroradiology, design and set up of clinical trials, device development and evaluation (CE-marking), high-fidelity medical simulation, reference site (core laboratory for clinical trials), set up of thrombectomy services |
| disorders of sexual development | *Consultant(s)* | *Towns* | Paediatric endocrinology and diabetes, metabolic bone disease, skeletal dysplasias, disorders of sexual development |
| drug development | *Consultant(s)* | *Towns* | Ischaemic heart disease, heart failure, cardiac electrophysiology, pacemaker/ICD - implantable cardioverter defibrillator implantation, drug development |
| drug development | *Consultant(s)* | *Towns* | Medical oncology, upper gastrointestinal cancer, melanoma, drug development |
| drug development | *Consultant(s)* | *Towns* | Medical oncology, ovarian cancer, angiogenesis, drug development |
| drug development | *Consultant(s)* | *Towns* | Medical oncology, drug development, ovarian cancer, endometrial cancer, cervical cancer, early phase clinical trials |
| drug development | *Consultant(s)* | *Towns* | Medical oncology, immunotherapy, targeted therapy, cancer biomarkers, drug development |
| drug development | *Consultant(s)* | *Towns* | Medical oncology, drug development, breast cancer, colorectal cancer |
| drug development - childhood cancer | *Consultant(s)* | *Towns* | Paediatric neuro-oncology, drug development - childhood cancer, the biology of childhood malignant glioma, drug development |
| DSD - disorders of sex development | *Consultant(s)* | *Towns* | Paediatric endocrinology, growth, puberty, bone growth, thyroid, pituitary, DSD - disorders of sex development |
| DSD - disorders of sex development - intersex | *Consultant(s)* | *Towns* | Paediatric urology, laparoscopy, hypospadias, paediatric stones, DSD - disorders of sex development - intersex |
| early drug development | *Consultant(s)* | *Towns* | Medical oncology, genito-urinary oncology, translational oncology, early drug development |
| gastrointestinal immunity and infections and vaccine development | *Consultant(s)* | *Towns* | IBD - inflammatory bowel disease, Crohn's disease, ulcerative colitis, gastrointestinal immunity and infections and vaccine development, nutrition and irritable bowel syndrome - IBS, dyspepsia and reflux disease, feeding tube placement and nutrition, endoscopic ultrasound and laser therapy |
| growth and development | *Consultant(s)* | *Towns* | Paediatric endocrinology, neuroendocrine and late effects of childhood malignancy, adolescence to 21yrs, growth and development, reproductive maturity, Turner's syndrome, congenital adrenal hyperplasia, short stature, paediatric endocrine oncology, pituitary tumours in childhood |
| guideline development | *Consultant(s)* | *Towns* | Paediatric rheumatology, juvenile idiopathic arthritis, guideline development, chronic recurrent multifocal osteomyelitis - CRMO/CNO, uveitis associated with juvenile idiopathic arthritis |
| healthcare pathway development | *Consultant(s)* | *Towns* | Adult ADHD, autism, healthcare pathway development, depressive disorder, schizophrenia |
| imaging in drug development | *Consultant(s)* | *Towns* | Diagnostic radiology, MRI, CT, oncology, functional MRI, imaging in drug development, prostate MRI |
| lung development | *Consultant(s)* | *Towns* | Paediatrics, primary ciliary dyskinesia - PCD, paediatric bronchiectasis and wet cough, lung development |
| molecular biomarker development | *Consultant(s)* | *Towns* | Molecular biology in cancer and causes of cancer, facial pain, human papillomavirus, head and neck cancer, bisphosphonate osteonecrosis, molecular biomarker development |
| new drug development | *Consultant(s)* | *Towns* | Medical oncology, gynaecological oncology, testicular cancer, new drug development, solid tumour cancers, ovarian cancer |
| new drug development in paediatric oncology | *Consultant(s)* | *Towns* | Brain tumours in childhood, liver tumours in childhood, bone and soft tissue tumours in childhood, new drug development in paediatric oncology |
| phase 1 drug development | *Consultant(s)* | *Towns* | Medical oncology, lung cancer, head and neck cancer, phase 1 drug development |
| service development in psychiatry | *Consultant(s)* | *Towns* | General adult psychiatry, bipolar affective disorder, service development in psychiatry, crisis resolution and home treatment |
| Service development in resource poor settings | *Consultant(s)* | *Towns* | Service development in resource poor settings, depression and anxiety in young people |
| Page No 1 |
